Cargando…
A case report of acquired immunodeficiency syndrome (AIDS)-related refractory Burkitt lymphoma got complete remission by multidisciplinary and multi-target combined therapy
BACKGROUND: The incidence of Burkitt lymphoma among acquired immunodeficiency syndrome (AIDS) patients is significantly higher than that in general populations. It often features high malignancy and a poor prognosis. For patients with AIDS-related Burkitt lymphoma, the guidelines recommend the dose-...
Autores principales: | Zhang, Renfang, Sun, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273674/ https://www.ncbi.nlm.nih.gov/pubmed/35836543 http://dx.doi.org/10.21037/tcr-22-1375 |
Ejemplares similares
-
A Case of Jejunal Intussusception caused by Burkitt Lymphoma in an Acquired Immunodeficiency Syndrome Patient
por: Baek, Dae-Youb, et al.
Publicado: (2018) -
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma
por: Bohler, Jeanne, et al.
Publicado: (2022) -
Nasopharyngeal Burkitt lymphoma as an early AIDS manifestation()
por: Mascarenhas, Juliana Gama, et al.
Publicado: (2014) -
Multiple cranial nerve palsies in immunodeficiency subtype of Burkitt lymphoma
por: Ali, Abbas, et al.
Publicado: (2018) -
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma
por: Raghunandan, Sharmila, et al.
Publicado: (2023)